Anders Björkman
Professor Emeritus/Emerita
Research description
My research has historically addressed challenges of improving diagnosis, treatment and control of Plasmodium falsiparum malaria.
Improving Diagnosis, Treatment and Control/Elimination of Plasmodium falciparum Malaria
A major aim has continuously been to apply new biomedical technologies to respond to parasitological, clinical and epidemiological research questions. That implies studies on diagnostic technologies and malaria therapies and studies on the possible evolution and selection of different genetic parasite alterations potentially associated to resistance to detection, diagnosis and/or treatment of P. falciparum.
A main overall aim is to address the research question “is it possible to eliminate malaria from a high endemic region, typical of sub Saharan Africa?”
Projects
- New strategies for malaria control - aiming at elimination in Zanzibar
- Modern artemisinin-based combination drugs against malaria - malaria drugs and evolution of resistance
- New tools and strategies for malaria diagnosis
Collaborations
- Zanzibar Malaria Control Program, Zanzibar Ministry of Health and Social Welfare, Tanzania
- Muhimbili University for Health and Allied Sciences, Dar es Salaam, Tanzania
- Malaria Research and Training Center, University of Bamako, Mali
Teaching portfolio
Dissertations
2013
- Maja Malmberg: The role of molecular markers in emerging artemether-lumefantrine resistant Plasmodium falciparum
2011
- Maria Isabel Mendes Veiga: Plasmodium falciparum drug transporter genes in emerging malaria multidrug resistance
2010
- Pedro Ferreira: Molecular basis for the mechanism of action and resistance to artemisinin combination therapy in Plasmodium falciparum
- Billy Ephraim Ngasala: Improved malaria case management in under-fives in the era of Artemisinin-based combination therapy in Tanzania
- Gabrielle Holmgren: Plasmodium falciparum resistance to amodiaquine in monotherapy and in combination therapy with artesunate
2009
- Johan Ursing: Plasmodium falciparum response to chloroquine and artemisinin based combination therapy (ACT) in Guinea-Bissau
- Sabina Dahlström: Role of PfATP6 and pfMRP1 in Plasmodium falciparum resistance to antimalarial drugs
- Christin Sisowath: The molecular basis of Plasmodium falciparum resistance to the antimalarial lumefantrine
2008
- Andreas Mårtensson: PCR adjusted cure rates in clinical trials of antimalarial drugs in Africa: Influence of extended follow-up and consecutive day
Licentiates
2009